Chemomab Therapeutics Ltd.
CMMB
$1.23
$0.010.82%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/5/2025
-
The Fly
5/5/2025
-
Globe Newswire
4/28/2025
-
GuruFocus
4/28/2025
-
The Fly
4/28/2025
-
Globe Newswire
4/21/2025
-
GuruFocus
4/21/2025
-
GuruFocus
4/21/2025
-
Globe Newswire
4/15/2025
-
GuruFocus
4/15/2025
-
The Fly
4/15/2025
-
Globe Newswire
3/27/2025
-
Benzinga
3/27/2025
-
The Fly
3/27/2025
-
Globe Newswire
3/7/2025
-
TipRanks Financial Blog
3/6/2025
-
The Fly
3/6/2025
-
Globe Newswire
3/4/2025
-
TipRanks Financial Blog
3/3/2025
-
TipRanks Financial Blog
3/3/2025
-
The Fly
3/3/2025
-
The Fly
3/3/2025
-
GuruFocus
3/3/2025
-
Globe Newswire
2/23/2025
-
Ticker Report
2/20/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Friday, April 4, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Aug 18 and 22 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 77 331 0156
Address
Building 7
Tel Aviv, 6158002
Tel Aviv, 6158002
Country
Year Founded
Business Description
Sector
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United...
more